Table 5 Univariate analysis on neurological deterioration within 7 days from onset
From: Baseline platelet count may predict short-term functional outcome of cerebral infarction
Neurological deterioration | - (350) | + (35) | P-value | ||
|---|---|---|---|---|---|
N | % | N | % | ||
sex (male) | 224 | 64.0 | 21 | 60.0 | 0.713 |
age | 69.0 ± 14.3 | 73.7 ± 15.4 | 0.318 | ||
BMI | 23.5 ± 3.43 | 23.6 ± 4.33 | 0.220 | ||
smoking habit | 72 | 20.5 | 8 | 22.8 | 0.827 |
hypertension | 264 | 75.4 | 25 | 71.4 | 0.682 |
diabetes | 147 | 42.0 | 11 | 31.4 | 0.280 |
dyslipidemia | 259 | 74.0 | 25 | 71.4 | 0.693 |
IHD | 37 | 10.45 | 1 | 2.8 | 0.231 |
Af | 84 | 24.0 | 10 | 28.5 | 0.540 |
history of CI | 49 | 14.0 | 11 | 31.4 | 0.853 |
NIHSS ≥ 8 | 37 | 10.5 | 10 | 28.5 | 0.005 |
WBC | 7048 ± 2555 | 7452 ± 2674 | 0.181 | ||
Hb | 13.8 ± 2.07 | 13.2 ± 2.27 | 0.161 | ||
Stroke subtype | |||||
SVO | 50 | 14.2 | 0 | 0 | 0.014 |
LAS | 37 | 10.5 | 10 | 28.5 | 0.005 |
CE | 98 | 28.0 | 9 | 25.7 | 0.846 |
BAD | 21 | 6.0 | 7 | 20.0 | 0.008 |
Pre-medication | |||||
CaB | 103 | 29.4 | 11 | 31.4 | 0.847 |
ARB | 86 | 24.5 | 5 | 14.2 | 0.213 |
ACE-I | 14 | 4.0 | 2 | 5.7 | 0.648 |
diuretics | 28 | 8.0 | 3 | 8.5 | 0.753 |
statins | 101 | 28.8 | 9 | 25.7 | 0.845 |
DPP4/GLP1 | 56 | 16.0 | 3 | 8.5 | 0.328 |
anticoagulant | 57 | 16.28 | 2 | 5.7 | 0.137 |
antiplatelet | 75 | 21.4 | 11 | 31.4 | 0.201 |